Understanding the Reclassification of Pharmaceutical Microorganisms
Reclassification of Pharmaceutical Microorganisms: Implications for Quality Control and Drug Safety Reclassification of Pharmaceutical Microorganisms: Implications for Quality Control and Drug Safety The field of pharmaceutical microbiology is continuously evolving, with advances in molecular techniques and genomic studies leading to the reclassification of several microorganisms quality control (QC) , regulatory compliance, and ensuring the safety of pharmaceutical products . 🔬 What is Microbial Reclassification? Microbial reclassification refers to the process of updating the taxonomy or naming of microorganisms based on new scientific evidence, often derived from: 16S rRNA gene sequencing Whole-genome sequencing Phylogenetic and biochemical analysis In pharmaceuticals, this has significant consequences, as regulatory documents, QC protocols, and compendial references often depend on correct microbial nomenclature. ⚖️ Common Examples of Reclassifi...